Eric Klein, M.D., is chair of Cleveland Clinic’s Glickman Urological & Kidney Institute. A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial...
Tag: <span>Prostate cancer</span>
Post
Will we soon have a jab for prostate cancer? Experts unveil a vaccine that could provide a cure for the disease
Vaccine that treats the disease by stimulating the immune system is being tested Jab stopped tumours from spreading for 77% of cancer patients in the trial And 45 per cent of patients in the clinical trial experienced tumour shrinkage Prostate cancer is one of the most common cancers, affecting one in seven men A vaccine...
Post
Advanced prostate cancer treatment failure due to cell reprogramming
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Columbia University Medical Center (CUMC) researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy. The findings, based on a study in mice, could help to determine which patients should...
Post
Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that
Precise MD uses fluorescent biomarkers and other features to tell harmless prostate cancer cells from aggressive ones.MOUNT SINAIThey look like glowing jade necklaces of such unearthly brilliance they could be a Ming emperor’s. But if Dr. Gerardo Fernandez is right, the green fluorescent images of prostate cells could be even more valuable, at least to...
Post
Men with prostate cancer can now be saved by a ‘wonder drug’ which boosts survival rates for women battling breast tumours
Research suggests a new ‘wonder drug’ could help men with prostate cancer The pill boosts survival in women battling genetic breast and ovarian cancer American actor Ben Stiller, 51, revealed he had been diagnosed with the disease A ‘wonder drug’ that boosts survival in women battling genetic breast and ovarian cancer may also be a...
Post
Should you get screened for prostate cancer? We break down the latest advice
A panel of experts in preventive medicine released a draft proposal Tuesday on screening for prostate cancer. “Another one?” you may ask, remembering an earlier recommendation. Don’t worry; we’re here to help you avoid whiplash: What’s new? What was emphatic before is wishy-washy now. The last time the US Preventive Services Task Force weighed in on prostate cancer...
Post
Study provides path for new immunotherapy approaches to prostate cancer
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine. Based...
Post
MRI use may “change the equation” for prostate cancer screening
Screening for prostate cancer is controversial. It can save lives, but it can also lead to unnecessary diagnoses, followed by surgical or radiation procedures, which themselves may lead to severe side-effects. Now a new study, coming from the Dutch part of the European Randomised study for the Screening of Prostate Cancer (ERSPC) has found that...
Post
Scientists report genetic test to help predict men at most risk from aggressive prostate cancer
Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure. This test, reported at the European Association of Urology conference in London, and published in the Journal of the National Cancer Institute, may give men a better view...
Post
New insights into side effects can help prostate cancer patients choose treatments
For many men newly diagnosed with early-stage prostate cancer, concerns about potential quality-of-life issues often guide treatment decisions. A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects that patients could use to guide their choices. In the Journal of the American Medical Association, the study examines quality-of-life outcomes...